NEW YORK, Nov. 16 (Xinhua) -- The U.S. dollar weakened in late trading on Monday as market participants digested fresh news on a COVID-19 vaccine candidate.
The dollar index, which measures the greenback against six major peers, was down 0.13 percent at 92.6362.
In late New York trading, the euro rose to 1.1844 U.S. dollars from 1.1831 dollars in the previous session, and the British pound increased to 1.3189 dollars from 1.3175 U.S. dollars in the previous session. The Australian dollar was up to 0.7313 U.S. dollar from 0.7263 dollar.
The U.S. dollar bought 104.58 Japanese yen, lower than 104.63 Japanese yen of the previous session. The U.S. dollar fell to 0.9126 Swiss franc from 0.9134 Swiss franc, and it fell to 1.3096 Canadian dollars from 1.3136 Canadian dollars.
Traders closely monitored the latest news on potential coronavirus vaccines.
U.S. biotechnology company Moderna said on Monday that its COVID-19 vaccine candidate appears to be 94.5 percent effective, according to preliminary data from the company's ongoing study.